Univariable and Multivariable cox regression model for cancer-specific survival in patients with non-nasopharyngeal HNLEC in the unadjusted and adjusted cohort.

Figshare2025-04-29 更新10

Univariate Cox regression analysis of 4-year progression-free survival and overall survival in relation to patients’ characteristics.

癌症生存分析

化疗疗效评估

a. only oral regimens: XELODA and UFUR groups;b. combined regimens: FOLFOX, XELOX, OXA then 5-FU and FL groups.Abbreviations: 4-y OS: 4-year overall survival; 4-y PFS: 4-year progression-free survival

Figshare2015-12-03 更新10

2010-2015 SEER-LUAD.zip

资源简介：

相关数据集